Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Federal health agencies including the NIH, FDA, and CDC laid off over 10,000 employees following a Supreme Court ruling.

Infant vaccination rates improved from 2023 to 2024, but millions of infants still do not receive routine vaccination.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The FDA sent letters instructing companies to stop their marketing of concentrated 7-OH, a compound found in kratom.

A resident of Northern Arizona recently died after being infected with the pneumonic plague, the first death in the US since 2007.

Digital inhalers can detect significant changes in physiologic and inhaler use metrics in the 14 days before COPD exacerbations.

Increased risk for all-cause and CVD mortality in OSA may be linked to a severe phenotype marked by objective excessive daytime sleepiness.

Moderna's Spikevax vaccine has been fully approved for children with high-risk conditions, the first vaccine to do so.

The CDC confirmed a nationwide uptick in COVID-19 cases, with increases seen in 25 states, suggesting a summer spike.

Patients with severe asthma who initiate biologics may reduce their risk for oral corticosteroids (OCS)-related new-onset adverse outcomes.